A trial looking at blinatumomab for acute lymphoblastic leukaemia that has not responded to treatment or has come back after treatment

Overview

Cancer types:

Acute leukaemia, Acute lymphoblastic leukaemia (ALL), Blood cancers, Leukaemia

Status:

Results

Phase:

Phase 2

Details

This trial looked at a drug called blinatumomab for people with acute lymphoblastic leukaemia (ALL). It was for people whose leukaemia hadn’t responded to treatment or it had come back after treatment.

Recruitment start: 13 January 2012

Recruitment end: 10 October 2013

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Adele Fielding

Supported by

Amgen

Experimental Cancer Medicine Centre (ECMC)

NIHR Clinical Research Network: Cancer

Other information

We have more information on the work of Professor Adele Fielding.

Last reviewed: 17 Mar 2016

CRUK internal database number: 9153

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Help and support

Questions for your doctor

What to ask your doctor about clinical trials.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.